Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2021-10-09
DOI
10.1089/cbr.2020.4342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway
- (2020) Yan Yu et al. Cell Death & Disease
- Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
- (2019) Yan-Lin Huang et al. Cancer Management and Research
- Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis
- (2019) Jean-Luc Raoul et al. Liver Cancer
- Impact of AAV2 and hepatitis B virus integration into genome on development of hepatocellular carcinoma in patients with prior hepatitis B virus infection
- (2019) Kenji Tatsuno et al. CLINICAL CANCER RESEARCH
- Regulation of TEAD Transcription Factors in Cancer Biology
- (2019) Hyunbin D. Huh et al. Cells
- Adeno-associated virus in the liver: natural history and consequences in tumour development
- (2019) Tiziana La Bella et al. GUT
- KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis
- (2019) Shaoshan Yang et al. ONCOGENE
- Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer
- (2019) Elisabeth Drucker et al. Cell Communication and Signaling
- LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non‐small‐cell lung cancer cells through activating TGF‐β pathway and IL‐6/JAK2/STAT3 pathway
- (2019) Jindong Shi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma
- (2019) Jun Liu et al. PeerJ
- Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2018) Jong Hwan Choi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma
- (2018) Bowie Y. Cheng et al. CANCER RESEARCH
- Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
- (2018) Delphine Maucort-Boulch et al. INTERNATIONAL JOURNAL OF CANCER
- A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy
- (2018) Dominic H. Moon et al. RADIOTHERAPY AND ONCOLOGY
- Transcriptional control of kidney cancer
- (2018) Danielle J. Sanchez et al. SCIENCE
- Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size
- (2018) Giovanni Battista Levi Sandri et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Laparoscopic surgery for large left lateral liver tumors: safety and oncologic outcomes
- (2018) Tsung-Han Yang et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- XPC is an RNA polymerase II cofactor recruiting ATAC to promoters by interacting with E2F1
- (2018) B. Bidon et al. Nature Communications
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis
- (2018) Jie Chen PLoS One
- Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma
- (2018) Roland Sonntag et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
- (2018) Quentin Bayard et al. Nature Communications
- Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
- (2018) Chai Hong Rim et al. RADIOTHERAPY AND ONCOLOGY
- Derivate Isocorydine (d-ICD) Suppresses Migration and Invasion of Hepatocellular Carcinoma Cell by Downregulating ITGA1 Expression
- (2017) Xiaoqin Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells
- (2017) Gennara Cavallaro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma
- (2017) Lindsey N. Kent et al. JOURNAL OF CLINICAL INVESTIGATION
- E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma
- (2017) Yi Lv et al. Journal of Cancer
- Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child-Pugh B cirrhosis
- (2016) Takeshi Terashima et al. CANCER SCIENCE
- Hepatitis B Virus X Protein Upregulates hELG1/ ATAD5 Expression through E2F1 in Hepatocellular Carcinoma
- (2016) Alip Ghosh et al. International Journal of Biological Sciences
- Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
- (2015) C. Hsu et al. CLINICAL CANCER RESEARCH
- Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan
- (2015) C.-C. Chiu et al. EJSO
- Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression
- (2015) Amy Tarangelo et al. Nature Communications
- POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation
- (2015) Boshi Wang et al. Nature Communications
- Aflatoxin B1 Promotes Cell Growth and Invasion in Hepatocellular Carcinoma HepG2 Cells through H19 and E2F1
- (2014) Jun Lv et al. Asian Pacific Journal of Cancer Prevention
- Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
- (2014) K W Hagberg et al. BRITISH JOURNAL OF CANCER
- Promising roles of mammalian E2Fs in hepatocellular carcinoma
- (2014) Lei Zhan et al. CELLULAR SIGNALLING
- Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity
- (2014) Zhonglei Lu et al. Nature Communications
- Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern
- (2013) H.M. El Tayebi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells
- (2013) Xiao Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Arsenic levels in drinking water and mortality of liver cancer in Taiwan
- (2013) Hung-Jung Lin et al. JOURNAL OF HAZARDOUS MATERIALS
- E2F transcription factors and digestive system malignancies: How much do we know?
- (2013) Athanasios Xanthoulis WORLD JOURNAL OF GASTROENTEROLOGY
- Role of E2F-1 and its involving pathway in esophageal squamous cell carcinoma
- (2013) Wen Wang et al. Thoracic Cancer
- The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma
- (2012) Yi-Ling Chen et al. ANNALS OF SURGICAL ONCOLOGY
- E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma
- (2012) Marina Palaiologou et al. VIRCHOWS ARCHIV
- The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes
- (2010) A. Docquier et al. CLINICAL CANCER RESEARCH
- Translating DNA damage into cancer cell death—A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
- (2010) David Engelmann et al. DRUG RESISTANCE UPDATES
- Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage
- (2010) Xiao-Peng Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MEME SUITE: tools for motif discovery and searching
- (2009) T. L. Bailey et al. NUCLEIC ACIDS RESEARCH
- Dual induction of PKR with E2F-1 and IFN-α to enhance gene therapy against hepatocellular carcinoma
- (2008) V Roh et al. CANCER GENE THERAPY
- E2F1 Inhibits c-Myc-Driven Apoptosis via PIK3CA/Akt/mTOR and COX-2 in a Mouse Model of Human Liver Cancer
- (2008) Sara Ladu et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started